Citation 148787

PAN,MH: LIANG,YC: LIN SHIAU,SY: ZHU,NQ: HO,CT: LIN,JK:. (2001). INDUCTION OF APOPTOSIS BY THE OOLONG TEA POLYPHENOL THEASINENSIN A THROUGH CYTOCHROME C RELEASE AND ACTIVATION OF CASPASE-9 AND CASPASE-3 IN HUMAN U937 CELLS.. 48(12)

Citation Details

TitleINDUCTION OF APOPTOSIS BY THE OOLONG TEA POLYPHENOL THEASINENSIN A THROUGH CYTOCHROME C RELEASE AND ACTIVATION OF CASPASE-9 AND CASPASE-3 IN HUMAN U937 CELLS.
AuthorsPAN,MH: LIANG,YC: LIN SHIAU,SY: ZHU,NQ: HO,CT: LIN,JK:
Year2001
Volume48
Issue12

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
THEASINENSIN A
ACTIVE
2
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
THEASINENSIN A
ACTIVE
3
APOPTOSIS INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEASINENSIN A
ACTIVE
4
CASPASE-3 STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEASINENSIN A
ACTIVE
5
POLY(ADP-RIBOSE) POLYMERASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEASINENSIN A
ACTIVE
6
REACTIVE OXYGEN SPECIES GENERATION STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEASINENSIN A
ACTIVE
7
TRANSMEMBRANE POTENTIAL DECREASE
PHARMACOLOGY OF COMPOUND - IN VITRO
THEASINENSIN A
ACTIVE
8
CYTOCHROME C RELEASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEASINENSIN A
ACTIVE
9
CASPASE-9 STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEASINENSIN A
ACTIVE
10
DNA FRAGMENTATION FACTOR-45 DEGRADATION INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEASINENSIN A
ACTIVE
11
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN
ACTIVE
12
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN
ACTIVE
13
APOPTOSIS INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN
ACTIVE
14
CASPASE-3 STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN
ACTIVE
15
POLY(ADP-RIBOSE) POLYMERASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN
ACTIVE
16
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3-GALLATE
ACTIVE
17
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3-GALLATE
ACTIVE
18
APOPTOSIS INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3-GALLATE
ACTIVE
19
CASPASE-3 STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3-GALLATE
ACTIVE
20
POLY(ADP-RIBOSE) POLYMERASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3-GALLATE
ACTIVE
21
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3'-GALLATE
ACTIVE
22
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3'-GALLATE
ACTIVE
23
APOPTOSIS INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3'-GALLATE
ACTIVE
24
CASPASE-3 STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3'-GALLATE
ACTIVE
25
POLY(ADP-RIBOSE) POLYMERASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3'-GALLATE
ACTIVE
26
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3-3'-DIGALLATE
ACTIVE
27
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3-3'-DIGALLATE
ACTIVE
28
APOPTOSIS INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3-3'-DIGALLATE
ACTIVE
29
CASPASE-3 STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3-3'-DIGALLATE
WEAK ACTIVITY
30
POLY(ADP-RIBOSE) POLYMERASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
THEAFLAVIN-3-3'-DIGALLATE
WEAK ACTIVITY
31
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOCATECHIN-3-O-GALLATE,EPI: (-):
ACTIVE
32
ANTIPROLIFERATION ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOCATECHIN-3-O-GALLATE,EPI: (-):
ACTIVE
33
APOPTOSIS INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOCATECHIN-3-O-GALLATE,EPI: (-):
ACTIVE
34
CASPASE-3 STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOCATECHIN-3-O-GALLATE,EPI: (-):
ACTIVE
35
POLY(ADP-RIBOSE) POLYMERASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOCATECHIN-3-O-GALLATE,EPI: (-):
INACTIVE
Show SPARQL Queries (1)